Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  iobenguane I 131
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
A Study Evaluating Ultratrace Iobenguane I 131 (MIBG) in Patients With Malignant Pheochromocytoma/Paraganglioma
Phase: Phase II
Type: Treatment
Age: 12 and over
Trial IDs: MIP-IB12B, NCI-2010-01344, NCT00874614
131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinistat
Phase: Phase II
Type: Treatment
Age: Over 24 months to less than 30 years
Trial IDs: N2011-01, NCI-2015-00640, NCT02035137
Vorinostat and Iobenguane I 131 in Treating Patients With Resistant or Relapsed Neuroblastoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 2 to 30
Trial IDs: NANT 2007-03, NCI-2009-01450, NANT-N2007-03, N2007-03, NCT01019850
Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients with Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy with Isotretinoin
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 1 to 30
Trial IDs: ANBL09P1, NCI-2011-01745, CDR0000682629, COG-ANBL09P1, NCT01175356
Iobenguane I 131 in Treating Patients With Refractory Neuroblastoma
Phase: No phase specified
Type: Treatment
Age: 1 and over
Trial IDs: 05161, NCI-2011-01902, 10-01071, H854-26387, NCT01370330
Iobenguane I 131 in Treating Patients With Refractory Neuroblastoma or Metastatic Pheochromocytoma
Phase: No phase specified
Type: Supportive care, Treatment
Age: 1 and over
Trial IDs: 2012LS107, NCI-2013-01933, NCT01850888
Expanded Access Protocol Using I131-MIBG
Phase: No phase specified
Type: Treatment
Age: 12 months and over
Trial IDs: JDI2007-01, NCI-2014-01104, NCT01590680
Start Over